A matched case-control study comparing features, treatment and outcomes between patients with non-IgM lymphoplasmacytic lymphoma and Waldenström macroglobulinemia.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jorge J,Castillo

第一单位： Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.

作者： Jorge J,Castillo ^[1] ; Gilad,Itchaki ^[2] ; Joshua N,Gustine ^[1] ; Kirsten,Meid ^[3] ; Catherine A,Flynn ^[1] ; Maria G,Demos ^[4] ; Maria L,Guerrera ^[1] ; Cristina,Jimenez ^[1] ; Amanda,Kofides ^[1] ; Xia,Liu ^[1] ; Manit,Munshi ^[1] ; Nicholas,Tsakmaklis ^[1] ; Christopher J,Patterson ^[1] ; Lian,Xu ^[1] ; Guang,Yang ^[1] ; Zachary R,Hunter ^[1] ; Steven P,Treon ^[1]

作者单位： Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA. ^[1] Department of Medicine, Harvard Medical School, Boston, MA, USA. ^[2] Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel. ^[3] Department of Medicine, Boston University School of Medicine, Boston, MA, USA. ^[4]

关键词 Waldenstrom’s macroglobulinaemia case–control study lymphoplasmacytic lymphoma response survival

主题词病例对照研究(Case-Control Studies);人类(Humans);淋巴瘤, B细胞(Lymphoma, B-Cell);突变(Mutation);治疗结果(Treatment Outcome);Waldenstrom巨球蛋白血症(Waldenstrom Macroglobulinemia)

DOI 10.1080/10428194.2020.1719100

PMID 31992103

发布时间 2021-04-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交